Quarterly report pursuant to Section 13 or 15(d)

4. Cash and Cash Equivalents

v3.8.0.1
4. Cash and Cash Equivalents
6 Months Ended
Sep. 30, 2017
Description Of Business  
Cash and Cash Equivalents
   

September 30,

2017

   

March 31,

2017

 
             
Securities purchased under agreement to resell   $ 18,103     $ 8,376  
Current account with commercial banks     9,360       9,204  
Current account in clearing organizations     2,454       191  
Current account with Central Depository (Kazakhstan)     2,153       984  
Petty cash     1,945       1,476  
Current account with National Settlement Depository (Russia)     1,654       696  
Current account with Central Bank (Russia)     1,185       645  
Brokerage accounts     1,017       259  
                 
Total cash and cash equivalents   $ 37,871     $ 21,831  

 

As of September 30, 2017 and March 31, 2017, cash and cash equivalents were not insured. As of September 30, 2017 and March 31, 2017, the cash and cash equivalents balance included collateralized securities received under agreement to resell on the terms presented below:

 

    September 30, 2017  
    Interest rates and remaining contractual maturity of the agreements  
    Average Interest rate     Up to 30 days     30-90 days     Total  
Securities purchased under agreement to resell                        
Corporate equity     16.86 %   $ 10,970     $ 2,490     $ 13,460  
Corporate debt     9.04 %     4,643       -       4,643  
                                 
Total           $ 15,613     $ 2,490     $ 18,103  

 

    March 31, 2017  
    Interest rates and remaining contractual maturity of the agreements  
    Average Interest rate     Up to 30 days     30-90 days     Total  
Securities purchased under agreement to resell                        
Corporate equity     19.56 %   $ 8,346     $ 25     $ 8,371  
Corporate debt     24.00 %     5       -       5  
                                 
Total           $ 8,351     $ 25     $ 8,376  

 

The securities received by the Company as collateral under reverse repurchase agreements (agreements to resell) are liquid trading securities with market quotes and significant trading volume.

 

The fair value of collateral received by the Company under reverse repurchase agreements as of September 30, 2017 and March 31, 2017, is $18,553 and $8,229, respectively.